Active	Status	Sponsor type	Region	Phase	Filter
8 Active 21 Inactive 29 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Taylor, Charles W
NCT06269146: Pramipexole to Enhance Social Connections	Recruiting	2	108	US	Pramipexole Pill, Mirapex, Placebo Pill	University of California, San Diego, National Institute of Mental Health (NIMH), New York State Psychiatric Institute	Anxiety Disorders, Anxiety, Depression, Social Disconnection	03/25	03/25
NCT05823753: Cannabidiol to Reduce Anxiety Reactivity	Completed	2	63	US	Cannabidiol, Epidiolex, Placebo	University of California, San Diego	Social Anxiety, Social Anxiety Disorder	08/24	08/24
Stein, Murray B
NCT05823753: Cannabidiol to Reduce Anxiety Reactivity	Completed	2	63	US	Cannabidiol, Epidiolex, Placebo	University of California, San Diego	Social Anxiety, Social Anxiety Disorder	08/24	08/24
NCT02256644: Genomics of Posttraumatic Stress Disorder in Veterans	Completed	N/A	20000	US		VA Office of Research and Development	PTSD	08/14	09/24
NCT04602806: Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1	Completed	N/A	50	US		University of California, San Francisco, U.S. Army Medical Research and Development Command	Traumatic Brain Injury	11/22	01/23
Smith, Taylor A
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.	Active, not recruiting	3	14013	Europe, Canada, US, RoW	Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml	Novartis Pharmaceuticals	Primary Prevention of Atherosclerotic Cardiovascular Disease	04/29	04/29
NCT05823753: Cannabidiol to Reduce Anxiety Reactivity	Completed	2	63	US	Cannabidiol, Epidiolex, Placebo	University of California, San Diego	Social Anxiety, Social Anxiety Disorder	08/24	08/24
NCT04945239: Amplification of Positivity to Enhance Social Connections in Anxiety and Depression	Completed	N/A	134	US	Amplification of Positivity Training (6 Sessions), Stress Management Training (6 Sessions)	University of California, San Diego	Depression, Anxiety Disorders and Symptoms	12/23	03/24